RB Consumer Provides Bright Spot In Dim Quarter Despite Slower Sales
This article was originally published in The Tan Sheet
Executive Summary
RB missed analysts third-quarter expectations by 1%, reporting a 2% sales increase to $3.82 billion. Consumer health product sales led the way with a 6% increase to $1.21 billion, dragged down slightly by slower than expected uptake of Mucinex and MegaRed products.